US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvalent, Inc.

82.75

-1.8400-2.18%

Volume:431.90K

Turnover:35.60M

Market Cap:5.94B

PE:-18.78

High:85.50

Open:85.03

Low:80.97

Close:84.59

Loading ...

Overview Company News Filings

BRIEF-Nuvalent appoints Christy Oliger to board of directors

Nuvalent Inc. Appoints Christy Oliger to Board of Directors Amid Strategic Shift Toward Commercialization

Nuvalent Appoints Christy Oliger to Board of Directors

THOMSON REUTERS

Press Release: Nuvalent Appoints Christy Oliger to Board of Directors

Barclays Keeps Their Buy Rating on Nuvalent (NUVL)

Nuvalent Inc. Announces Board Member Emily Conley's Resignation Effective at 2025 Annual Meeting

Nuvalent, Inc. Reports Q1 2025 Financial Results

Nuvalent’s Strategic Progress and Financial Stability Drive Buy Rating

Nuvalent Q1 EPS $(1.18) Misses $(1.09) Estimate

Nuvalent Q1 EPS USD -1.18

THOMSON REUTERS

Press Release: Nuvalent Outlines Recent Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2025 Financial Results

Nuvalent Announces Publication in Molecular Cancer Therapeutics Reinforcing Rational Molecular Design of Zidesamtinib as a Novel ROS1-Selective Inhibitor

Nuvalent Board Member Resigns, Joins Advisory Board

Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Brainstorm Cell Therapeutics (BCLI)

Is Nuvalent (NUVL) the Best Debt Free Mid Cap Stock to Buy Now?

Nuvalent to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

Optimistic Outlook on Nuvalent’s Zidesaminib: Promising Phase 1 Results and Strategic Positioning in ROS1-Positive NSCLC Market

Nuvalent Raised to Buy From Neutral by UBS

UBS Upgrades Nuvalent to Buy From Neutral, Maintains $100 Price Target

MT Newswires Live

Nuvalent’s Promising Oncology Position and Strategic Differentiation Justify Buy Rating

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NUVL/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NUVL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NUVL\",,,,,undefined,":{"symbol":"NUVL","market":"US","secType":"STK","nameCN":"Nuvalent, Inc.","latestPrice":82.75,"timestamp":1752608743660,"preClose":84.59,"halted":0,"volume":431898,"delay":0,"floatShares":41263836,"shares":71808765,"eps":-4.406658,"marketStatus":"Trading","change":-1.84,"latestTime":"07-15 15:45:46 EDT","open":85.03,"high":85.5,"low":80.97,"amount":35597184.3243,"amplitude":0.053552,"askPrice":83.07,"askSize":143,"bidPrice":82.84,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.406658,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1752609600000},"marketStatusCode":2,"adr":0,"listingDate":1627531200000,"exchange":"NASDAQ","adjPreClose":84.59,"preHourTrading":{"tag":"盘前","latestPrice":85.29,"preClose":84.59,"latestTime":"09:29 EDT","volume":607,"amount":51839.347850000006,"timestamp":1752586199999},"postHourTrading":{"tag":"盘后","latestPrice":86.26,"preClose":84.59,"latestTime":"16:50 EDT","volume":21884,"amount":1851570.71,"timestamp":1752526237295},"volumeRatio":1.022914,"impliedVol":0.4852,"impliedVolPercentile":0.432},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NUVL\",,,,,undefined,":{"symbol":"NUVL","floatShares":41263836,"roa":"-22.23%","roe":"-35.69%","lyrEps":-3.926527,"volumeRatio":1.022914,"shares":71808765,"dividePrice":0,"high":85.5,"amplitude":0.053552,"preClose":84.59,"low":80.97,"week52Low":55.535,"pbRate":"5.88","week52High":113.51,"institutionHeld":0,"latestPrice":82.75,"committee":-0.176955,"eps":-4.406658,"divideRate":0,"volume":431898,"delay":0,"ttmEps":-4.406658,"open":85.03,"prevYearClose":78.28,"prevWeekClose":80.93,"prevMonthClose":76.3,"prevQuarterClose":76.3,"fiveDayClose":78.77,"twentyDayClose":78.24,"sixtyDayClose":69.97},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NUVL\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544718896","title":"BRIEF-Nuvalent appoints Christy Oliger to board of directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2544718896","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544718896?lang=en_us&edition=fundamental","pubTime":"2025-06-19 04:32","pubTimestamp":1750278733,"startTime":"0","endTime":"0","summary":"BRIEF-Nuvalent appoints Christy Oliger to board of directorsJune 18 (Reuters) - Nuvalent Inc NUVL.O:NUVALENT APPOINTS CHRISTY OLIGER TO BOARD OF DIRECTORSSource text: ID:nPn85ygnbaFurther company coverage: NUVL.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nTUA8B8YRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2544188624","title":"Nuvalent Inc. Appoints Christy Oliger to Board of Directors Amid Strategic Shift Toward Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2544188624","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544188624?lang=en_us&edition=fundamental","pubTime":"2025-06-19 04:30","pubTimestamp":1750278625,"startTime":"0","endTime":"0","summary":"Nuvalent, Inc., a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, has appointed Christy Oliger to its Board of Directors. Oliger, who brings over 30 years of experience in the pharmaceutical and biotechnology industry, was previously the Senior Vice President of the Oncology Business Unit at Genentech. Her appointment comes as Nuvalent prepares for potential commercialization of its novel kinase inhibitors in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via PR Newswire  on June 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDLb159wX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","BK4539","BK4139"],"gpt_icon":0},{"id":"2544418864","title":"Nuvalent Appoints Christy Oliger to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2544418864","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544418864?lang=en_us&edition=fundamental","pubTime":"2025-06-19 04:30","pubTimestamp":1750278602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nTUA8B8YRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2544188966","title":"Press Release: Nuvalent Appoints Christy Oliger to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2544188966","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544188966?lang=en_us&edition=fundamental","pubTime":"2025-06-19 04:30","pubTimestamp":1750278600,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., June 18, 2025 /PRNewswire/ -- Nuvalent, Inc. , a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the appointment of Christy Oliger to its Board of Directors.\"Christy's proven success in delivering new therapies to patients living with cancer strengthens our Board as we evolve from a development-stage company toward potential commercialization,\" said James Porter, Ph.D., Chief Executive Officer at Nuvalent. \"We welcome her deep expertise and valuable perspective to our team as we prepare for a potential first approval from our pipeline of novel kinase inhibitors in 2026.\". Ms. Oliger brings more than 30 years of commercial and business experience in the pharmaceutical and biotechnology industry to the Nuvalent Board. Most recently, Ms. Oliger served as Senior Vice President of the Oncology Business Unit at Genentech, where she was responsible for all commercial act","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2544924166","title":"Barclays Keeps Their Buy Rating on Nuvalent (NUVL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2544924166","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544924166?lang=en_us&edition=fundamental","pubTime":"2025-06-18 17:05","pubTimestamp":1750237532,"startTime":"0","endTime":"0","summary":"Barclays analyst Peter Lawson maintained a Buy rating on Nuvalent (NUVL – Research Report) today and set a price target of $100.00. The company’s s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-buy-rating-on-nuvalent-nuvl-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-buy-rating-on-nuvalent-nuvl-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Barclays Keeps Their Buy Rating on Nuvalent (NUVL)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL"],"gpt_icon":0},{"id":"2542134039","title":"Nuvalent Inc. Announces Board Member Emily Conley's Resignation Effective at 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542134039","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542134039?lang=en_us&edition=fundamental","pubTime":"2025-06-11 04:37","pubTimestamp":1749587867,"startTime":"0","endTime":"0","summary":"Nuvalent Inc. has announced a change in its board of directors. Emily Conley has decided to resign from her position on the board and all related committees, effective at the time of the company's 2025 annual meeting of stockholders. Her resignation is not due to any disagreements with the company's operations, policies, or practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL3S8Jcn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2539202147","title":"Nuvalent, Inc. Reports Q1 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2539202147","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539202147?lang=en_us&edition=fundamental","pubTime":"2025-05-31 11:51","pubTimestamp":1748663504,"startTime":"0","endTime":"0","summary":"Nuvalent, Inc. Class A ( ($NUVL) ) has released its Q1 earnings. Here is a breakdown of the information Nuvalent, Inc. Class A presented to its inv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nuvalent-inc-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nuvalent-inc-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL","BK4139","BK4539"],"gpt_icon":0},{"id":"2534896431","title":"Nuvalent’s Strategic Progress and Financial Stability Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2534896431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534896431?lang=en_us&edition=fundamental","pubTime":"2025-05-09 22:55","pubTimestamp":1746802515,"startTime":"0","endTime":"0","summary":"Analyst Charles Zhu of LifeSci Capital maintained a Buy rating on Nuvalent (NUVL – Research Report), retaining the price target of $110.00. Charles...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/nuvalents-strategic-progress-and-financial-stability-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/nuvalents-strategic-progress-and-financial-stability-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL","PRGS"],"gpt_icon":0},{"id":"2533418186","title":"Nuvalent Q1 EPS $(1.18) Misses $(1.09) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533418186","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533418186?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:40","pubTimestamp":1746704419,"startTime":"0","endTime":"0","summary":"Nuvalent (NASDAQ:NUVL) reported quarterly losses of $(1.18) per share which missed the analyst consensus estimate of $(1.09) by 8.26 percent. This is a 71.01 percent decrease over losses of $(0.69) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45282270/nuvalent-q1-eps-1-18-misses-1-09-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL"],"gpt_icon":0},{"id":"2533186574","title":"Nuvalent Q1 EPS USD -1.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2533186574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533186574?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:31","pubTimestamp":1746703893,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nPLX747610:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2533863781","title":"Press Release: Nuvalent Outlines Recent Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533863781","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533863781?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:31","pubTimestamp":1746703860,"startTime":"0","endTime":"0","summary":"Nuvalent Outlines Recent Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2025 Financial Results. Topline pivotal data expected for zidesamtinib in TKI pre-treated ROS1-positive NSCLC population in the first half of 2025 in support of anticipated first NDA submission by mid-year 2025. Initiation of ALKAZAR Phase 3 randomized, controlled trial of neladalkib for front-line ALK-positive NSCLC planned for first half of 2025. Pivotal data for neladalkib in TKI pre-treated ALK-positive NSCLC population anticipated by year-end 2025. \"2025 is a critical year of execution for Nuvalent as we continue to transition toward becoming a fully integrated commercial-stage biopharmaceutical company,\" said James Porter, Ph.D., Chief Executive Officer at Nuvalent. \"We expect multiple meaningful milestones this year, including pivotal data for TKI pre-treated patients from both of our parallel lead programs, and our first potential NDA submission for zidesamt","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STRK","NUVL","BK4588","BK4023","R","BK4595","BK4022","PRGS","BK4600","BK4097","BK4232","BK4596","BK4585","BK4539","BK4516","LU2065732104.USD","BK4139"],"gpt_icon":1},{"id":"2531761270","title":"Nuvalent Announces Publication in Molecular Cancer Therapeutics Reinforcing Rational Molecular Design of Zidesamtinib as a Novel ROS1-Selective Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2531761270","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531761270?lang=en_us&edition=fundamental","pubTime":"2025-04-30 01:09","pubTimestamp":1745946540,"startTime":"0","endTime":"0","summary":"\"Zidesamtinib was specifically designed with the goal of addressing the combined medical needs of treating tumors that have developed resistance, treating brain metastases and avoiding off-target adverse events. Structural studies play a critical role in the development and optimization of novel therapeutics, particularly when aiming to solve for multiple, and at times competing, challenges. To date, structural studies for ROS1-positive cancers have been hindered by a lack of ROS1 G2032R crystal structures, despite G2032R being the most commonly occurring ROS1 resistance mutation,\" said first author Anupong Tangpeerachaikul, Ph.D., Director, Biology at Nuvalent. \"With this publication inMolecular Cancer Therapeutics, we are pleased to have shared what is, to our knowledge, the first structure of ROS1 G2032R, or any ROS1 mutation, offering a framework for understanding ROS1 TKI activity against these important drivers of disease progression. This structure further illustrates the intent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nuvalent-announces-publication-molecular-cancer-170900549.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nuvalent-announces-publication-molecular-cancer-170900549.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","NUVL","BK4539","BK4007","LENZ","BK4135","CNS"],"gpt_icon":0},{"id":"2528779133","title":"Nuvalent Board Member Resigns, Joins Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2528779133","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528779133?lang=en_us&edition=fundamental","pubTime":"2025-04-18 05:18","pubTimestamp":1744924682,"startTime":"0","endTime":"0","summary":"The latest update is out from Nuvalent ( ($NUVL) ). On April 11, 2025, D. Gary Gilliland, M.D., Ph.D., announced his resignation from the board of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nuvalent-board-member-resigns-joins-advisory-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nuvalent-board-member-resigns-joins-advisory-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2526731884","title":"Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Brainstorm Cell Therapeutics (BCLI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2526731884","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526731884?lang=en_us&edition=fundamental","pubTime":"2025-04-10 01:00","pubTimestamp":1744218022,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nuvalent (NUVL – Research Report), Brainstorm Cell T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-nuvalent-nuvl-brainstorm-cell-therapeutics-bcli?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-nuvalent-nuvl-brainstorm-cell-therapeutics-bcli?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL","BK4539","BCLI","HCSG","BK4137","BK4139"],"gpt_icon":0},{"id":"2524157531","title":"Is Nuvalent (NUVL) the Best Debt Free Mid Cap Stock to Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524157531","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524157531?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:25","pubTimestamp":1743510349,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Debt Free Mid Cap Stocks to Buy Now. In this article, we are going to take a look at where Nuvalent, Inc.  stands against the other debt free mid cap stocks.Debt-free mid-cap stocks currently offer compelling investment opportunities, especially in today’s high-interest-rate environment. With borrowing costs elevated, companies burdened by debt face increased financial pressure, making debt-free businesses more resilient and attractive. Mid-cap stocks, in particular, balance growth potential with relative stability, often providing more agility and higher upside than large-cap counterparts. Moreover, companies with strong balance sheets and zero debt have more cash capacity to reinvest profits into growth initiatives rather than servicing the debt. As legendary investor Peter Lynch succinctly advised, “Companies that have no debt can’t go bankrupt,” highlighting the inherent safety and resilience found in debt-free investments.The problem of h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nuvalent-nuvl-best-debt-free-122549855.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","TQQQ","BK4139","USAW.SI","TSYW.SI","QLD",".IXIC","MNQmain","NUVL","NVIW.SI","SQQQ","QID","USJW.SI","BK4539","NQmain"],"gpt_icon":1},{"id":"2524199405","title":"Nuvalent to Participate in the Stifel 2025 Virtual Targeted Oncology Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2524199405","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524199405?lang=en_us&edition=fundamental","pubTime":"2025-04-01 18:30","pubTimestamp":1743503400,"startTime":"0","endTime":"0","summary":"A live webcast will be available in the Investors section of the company's website atwww.nuvalent.com, and archived for 30 days following the presentations.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nuvalent-participate-stifel-2025-virtual-103000251.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nuvalent-participate-stifel-2025-virtual-103000251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NUVL","BK4179","SF","BK4127","BK4539","FET","BK4139"],"gpt_icon":0},{"id":"2523916008","title":"Optimistic Outlook on Nuvalent’s Zidesaminib: Promising Phase 1 Results and Strategic Positioning in ROS1-Positive NSCLC Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2523916008","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523916008?lang=en_us&edition=fundamental","pubTime":"2025-03-31 17:45","pubTimestamp":1743414321,"startTime":"0","endTime":"0","summary":"Nuvalent (NUVL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Charles Zhu from LifeSci Ca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/optimistic-outlook-on-nuvalents-zidesaminib-promising-phase-1-results-and-strategic-positioning-in-ros1-positive-nsclc-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/optimistic-outlook-on-nuvalents-zidesaminib-promising-phase-1-results-and-strategic-positioning-in-ros1-positive-nsclc-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","NUVL","BK4139"],"gpt_icon":0},{"id":"2519180479","title":"Nuvalent Raised to Buy From Neutral by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2519180479","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519180479?lang=en_us&edition=fundamental","pubTime":"2025-03-14 21:25","pubTimestamp":1741958700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NUVL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 14, 2025 09:25 ET (13:25 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL"],"gpt_icon":0},{"id":"2519877702","title":"UBS Upgrades Nuvalent to Buy From Neutral, Maintains $100 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2519877702","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519877702?lang=en_us&edition=fundamental","pubTime":"2025-03-14 19:23","pubTimestamp":1741951404,"startTime":"0","endTime":"0","summary":"Nuvalent (NUVL) has an average rating of buy and mean price target of $113.55, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NUVL"],"gpt_icon":0},{"id":"2516663111","title":"Nuvalent’s Promising Oncology Position and Strategic Differentiation Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663111","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516663111?lang=en_us&edition=fundamental","pubTime":"2025-03-04 04:35","pubTimestamp":1741034126,"startTime":"0","endTime":"0","summary":"Charles Zhu, an analyst from LifeSci Capital, maintained the Buy rating on Nuvalent (NUVL – Research Report). The associated price target remains t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/nuvalents-promising-oncology-position-and-strategic-differentiation-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/nuvalents-promising-oncology-position-and-strategic-differentiation-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NUVL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"NUVL","fiscalQuarterEnding":"2025/03","expectedEps":-1.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-1.18},{"market":"US","date":"2021-09-08","symbol":"NUVL","fiscalQuarterEnding":"2021/06","expectedEps":-0.21,"name":null,"time":"","type":"earning","dateTimestamp":1631073600000,"reportTimeType":"","actualEps":-3.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NUVL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NUVL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3846,"buy":0.6154,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6154,"analysts":13,"updateTime":1751515200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NUVL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NUVL","date":"2025-07-14","current":-19.316495,"percent":0.744306,"low":-69.351693,"twenty":-35.989565,"median":-25.988967,"eighty":-17.812724,"high":-6.26114,"avg":-27.060972,"sd":10.985737,"marketCap":5811483351},"quantilePoints":[{"date":"2021-07-30","current":-32.003439,"twenty":-32.354161,"median":-30.636831,"eighty":-29.270224,"marketCap":854491809},{"date":"2021-08-06","current":-39.893047,"twenty":-43.683429,"median":-39.621789,"eighty":-30.910153,"marketCap":1065144356},{"date":"2021-08-13","current":-40.471731,"twenty":-41.958227,"median":-39.504244,"eighty":-32.529523,"marketCap":1080595226},{"date":"2021-08-20","current":-48.862653,"twenty":-46.591318,"median":-40.471731,"eighty":-36.252451,"marketCap":1304632842},{"date":"2021-08-27","current":-62.732992,"twenty":-50.544455,"median":-43.437488,"eighty":-38.56569,"marketCap":1674970884},{"date":"2021-09-03","current":-68.881512,"twenty":-60.248267,"median":-45.860729,"eighty":-39.075655,"marketCap":1839136379},{"date":"2021-09-10","current":-65.348412,"twenty":-63.759706,"median":-47.741452,"eighty":-39.480734,"marketCap":1828513906},{"date":"2021-09-17","current":-62.94983,"twenty":-64.761708,"median":-50.860923,"eighty":-39.730292,"marketCap":1761399189},{"date":"2021-09-24","current":-39.44718,"twenty":-64.530478,"median":-49.278583,"eighty":-39.730292,"marketCap":1103771531},{"date":"2021-10-01","current":-41.63869,"twenty":-64.170784,"median":-47.714326,"eighty":-39.410891,"marketCap":1165092171},{"date":"2021-10-08","current":-31.371379,"twenty":-63.759706,"median":-45.860729,"eighty":-38.543989,"marketCap":877802556},{"date":"2021-10-15","current":-34.391176,"twenty":-63.187962,"median":-44.468269,"eighty":-35.519718,"marketCap":962299502},{"date":"2021-10-22","current":-34.529224,"twenty":-62.863095,"median":-42.812096,"eighty":-35.340256,"marketCap":966162219},{"date":"2021-10-29","current":-42.156369,"twenty":-62.364081,"median":-41.897529,"eighty":-36.171994,"marketCap":1179577362},{"date":"2021-11-05","current":-50.180402,"twenty":-61.727974,"median":-42.812096,"eighty":-36.430833,"marketCap":1404097818},{"date":"2021-11-12","current":-34.028754,"twenty":-60.644972,"median":-42.648165,"eighty":-36.184709,"marketCap":1212410461},{"date":"2021-11-19","current":-33.039467,"twenty":-58.433025,"median":-41.63869,"eighty":-35.340256,"marketCap":1177163164},{"date":"2021-11-26","current":-27.740684,"twenty":-57.008396,"median":-40.965706,"eighty":-34.418786,"marketCap":988372845},{"date":"2021-12-03","current":-27.063091,"twenty":-55.474121,"median":-40.006605,"eighty":-33.154505,"marketCap":964230860},{"date":"2021-12-10","current":-29.08232,"twenty":-53.340223,"median":-39.44718,"eighty":-32.23948,"marketCap":1036173974},{"date":"2021-12-17","current":-30.952478,"twenty":-52.342712,"median":-39.01578,"eighty":-31.220564,"marketCap":1102805851},{"date":"2021-12-23","current":-26.0467,"twenty":-51.940512,"median":-38.554839,"eighty":-29.461772,"marketCap":928017884},{"date":"2021-12-31","current":-25.802767,"twenty":-50.991433,"median":-38.204749,"eighty":-29.258494,"marketCap":919326769},{"date":"2022-01-07","current":-19.785735,"twenty":-50.180402,"median":-37.074482,"eighty":-28.635108,"marketCap":704945947},{"date":"2022-01-14","current":-17.210879,"twenty":-49.278583,"median":-36.755246,"eighty":-27.835548,"marketCap":613206406},{"date":"2022-01-21","current":-16.723012,"twenty":-48.945839,"median":-36.461894,"eighty":-27.290762,"marketCap":595824177},{"date":"2022-01-28","current":-17.590331,"twenty":-48.274083,"median":-36.023835,"eighty":-26.393628,"marketCap":626725917},{"date":"2022-02-04","current":-19.528249,"twenty":-47.81855,"median":-34.8916,"eighty":-26.000624,"marketCap":695771993},{"date":"2022-02-11","current":-24.325612,"twenty":-47.698051,"median":-34.304828,"eighty":-25.474811,"marketCap":866697243},{"date":"2022-02-18","current":-24.108782,"twenty":-47.445386,"median":-33.614657,"eighty":-24.726748,"marketCap":858971808},{"date":"2022-02-25","current":-21.018955,"twenty":-46.753363,"median":-32.880245,"eighty":-23.908215,"marketCap":748884359},{"date":"2022-03-04","current":-20.463328,"twenty":-46.073478,"median":-32.376852,"eighty":-22.116657,"marketCap":729087931},{"date":"2022-03-11","current":-21.005403,"twenty":-45.876805,"median":-31.765591,"eighty":-21.612527,"marketCap":748401519},{"date":"2022-03-18","current":-16.289352,"twenty":-45.336102,"median":-31.130443,"eighty":-21.013534,"marketCap":580373307},{"date":"2022-03-25","current":-17.102464,"twenty":-44.94676,"median":-29.461772,"eighty":-20.382017,"marketCap":609343688},{"date":"2022-04-01","current":-15.39984,"twenty":-44.68041,"median":-29.270224,"eighty":-19.994434,"marketCap":713597794},{"date":"2022-04-08","current":-13.710758,"twenty":-44.217879,"median":-29.08232,"eighty":-18.704295,"marketCap":635329113},{"date":"2022-04-14","current":-12.397028,"twenty":-43.553225,"median":-28.729971,"eighty":-18.145958,"marketCap":574453471},{"date":"2022-04-22","current":-11.343958,"twenty":-42.840121,"median":-28.228552,"eighty":-17.273218,"marketCap":525656330},{"date":"2022-04-29","current":-10.728799,"twenty":-42.680951,"median":-27.835548,"eighty":-17.086202,"marketCap":497151070},{"date":"2022-05-06","current":-10.926901,"twenty":-42.353087,"median":-27.38156,"eighty":-16.790771,"marketCap":506330730},{"date":"2022-05-13","current":-6.7688,"twenty":-41.949297,"median":-26.954676,"eighty":-16.549548,"marketCap":386512008},{"date":"2022-05-20","current":-6.819566,"twenty":-41.526351,"median":-26.487136,"eighty":-16.27309,"marketCap":389410848},{"date":"2022-05-27","current":-7.987184,"twenty":-41.200988,"median":-26.0467,"eighty":-15.742753,"marketCap":456084169},{"date":"2022-06-03","current":-7.775659,"twenty":-40.866911,"median":-26.033148,"eighty":-14.722122,"marketCap":444005669},{"date":"2022-06-10","current":-7.919496,"twenty":-40.401417,"median":-25.836647,"eighty":-13.721184,"marketCap":452219049},{"date":"2022-06-17","current":-8.477922,"twenty":-40.07474,"median":-25.545281,"eighty":-12.528401,"marketCap":484106290},{"date":"2022-06-24","current":-11.498499,"twenty":-39.893047,"median":-24.827032,"eighty":-12.282337,"marketCap":656587273},{"date":"2022-07-01","current":-11.464655,"twenty":-39.621789,"median":-24.09523,"eighty":-11.740163,"marketCap":654654713},{"date":"2022-07-08","current":-15.39902,"twenty":-39.482102,"median":-23.614139,"eighty":-11.765186,"marketCap":879314818},{"date":"2022-07-15","current":-14.121409,"twenty":-39.398794,"median":-22.27928,"eighty":-11.796764,"marketCap":806360676},{"date":"2022-07-22","current":-12.903025,"twenty":-39.172792,"median":-21.750757,"eighty":-11.911231,"marketCap":736788515},{"date":"2022-07-29","current":-12.573046,"twenty":-38.953658,"median":-21.547478,"eighty":-12.213523,"marketCap":717946054},{"date":"2022-08-05","current":-13.613749,"twenty":-38.669722,"median":-21.018955,"eighty":-12.041695,"marketCap":777372276},{"date":"2022-08-12","current":-12.344485,"twenty":-38.522289,"median":-20.829229,"eighty":-12.041695,"marketCap":811402986},{"date":"2022-08-19","current":-11.814173,"twenty":-38.3924,"median":-20.361689,"eighty":-12.011358,"marketCap":776545578},{"date":"2022-08-26","current":-11.593209,"twenty":-38.23687,"median":-20.124532,"eighty":-11.962731,"marketCap":762021658},{"date":"2022-09-02","current":-12.337119,"twenty":-37.455071,"median":-19.873822,"eighty":-11.913447,"marketCap":810918855},{"date":"2022-09-09","current":-12.955817,"twenty":-37.250109,"median":-19.121693,"eighty":-11.888628,"marketCap":851585830},{"date":"2022-09-16","current":-13.022106,"twenty":-37.041696,"median":-18.281477,"eighty":-11.956614,"marketCap":855943006},{"date":"2022-09-23","current":-12.35185,"twenty":-36.880877,"median":-17.841041,"eighty":-11.986524,"marketCap":811887116},{"date":"2022-09-30","current":-14.318424,"twenty":-36.797586,"median":-17.305742,"eighty":-12.008096,"marketCap":941150003},{"date":"2022-10-07","current":-13.684996,"twenty":-36.724185,"median":-17.197327,"eighty":-12.034926,"marketCap":899514766},{"date":"2022-10-14","current":-15.268566,"twenty":-36.558528,"median":-17.07536,"eighty":-12.071402,"marketCap":1003602858},{"date":"2022-10-21","current":-14.649869,"twenty":-36.430833,"median":-16.885634,"eighty":-12.126467,"marketCap":962935882},{"date":"2022-10-28","current":-26.02948,"twenty":-36.184709,"median":-16.736563,"eighty":-12.171497,"marketCap":1710917752},{"date":"2022-11-04","current":-26.315342,"twenty":-36.021716,"median":-16.933065,"eighty":-12.236034,"marketCap":1729707455},{"date":"2022-11-11","current":-24.734689,"twenty":-35.340256,"median":-17.102464,"eighty":-12.277734,"marketCap":1806127008},{"date":"2022-11-18","current":-23.845786,"twenty":-34.8916,"median":-17.231207,"eighty":-12.315206,"marketCap":1741219318},{"date":"2022-11-25","current":-24.927929,"twenty":-34.74665,"median":-17.380277,"eighty":-12.340065,"marketCap":1820237375},{"date":"2022-12-02","current":-27.849714,"twenty":-34.474005,"median":-18.091751,"eighty":-12.347431,"marketCap":2033586128},{"date":"2022-12-09","current":-23.96946,"twenty":-34.322098,"median":-18.484755,"eighty":-12.360689,"marketCap":1750249953},{"date":"2022-12-16","current":-22.856399,"twenty":-34.14259,"median":-19.528249,"eighty":-12.383179,"marketCap":1668974238},{"date":"2022-12-23","current":-21.982955,"twenty":-33.863115,"median":-19.989013,"eighty":-12.401198,"marketCap":1605195378},{"date":"2022-12-30","current":-23.01872,"twenty":-33.499619,"median":-20.151635,"eighty":-12.411064,"marketCap":1680826946},{"date":"2023-01-06","current":-21.526909,"twenty":-33.039467,"median":-20.361689,"eighty":-12.425505,"marketCap":1571894911},{"date":"2023-01-13","current":-25.067062,"twenty":-32.880245,"median":-20.692113,"eighty":-12.43287,"marketCap":1830396839},{"date":"2023-01-20","current":-23.868975,"twenty":-32.667097,"median":-20.829229,"eighty":-12.43287,"marketCap":1742912562},{"date":"2023-01-27","current":-25.09025,"twenty":-32.607408,"median":-21.018955,"eighty":-12.454243,"marketCap":1832090083},{"date":"2023-02-03","current":-23.242878,"twenty":-32.23948,"median":-21.295022,"eighty":-12.497137,"marketCap":1697194972},{"date":"2023-02-10","current":-22.160736,"twenty":-32.032331,"median":-21.41483,"eighty":-12.512417,"marketCap":1618176916},{"date":"2023-02-17","current":-25.144358,"twenty":-31.813161,"median":-21.547478,"eighty":-12.561215,"marketCap":1836040986},{"date":"2023-02-24","current":-23.258337,"twenty":-31.529064,"median":-21.655893,"eighty":-12.61268,"marketCap":1698323802},{"date":"2023-03-03","current":-23.150123,"twenty":-31.258268,"median":-21.825291,"eighty":-12.655311,"marketCap":1690421996},{"date":"2023-03-10","current":-20.483415,"twenty":-31.11996,"median":-21.77786,"eighty":-12.694101,"marketCap":1495698928},{"date":"2023-03-17","current":-21.066674,"twenty":-31.002698,"median":-21.750757,"eighty":-12.767298,"marketCap":1724391538},{"date":"2023-03-24","current":-19.133888,"twenty":-30.058054,"median":-21.655893,"eighty":-12.828665,"marketCap":1566185277},{"date":"2023-03-31","current":-18.073973,"twenty":-29.453641,"median":-21.544923,"eighty":-12.858593,"marketCap":1479427005},{"date":"2023-04-06","current":-16.335159,"twenty":-29.377022,"median":-21.488261,"eighty":-12.867431,"marketCap":1337098075},{"date":"2023-04-14","current":-19.85701,"twenty":-29.270224,"median":-21.3442,"eighty":-12.881669,"marketCap":1625375676},{"date":"2023-04-21","current":-23.2682,"twenty":-29.265532,"median":-21.362124,"eighty":-12.924142,"marketCap":1904595240},{"date":"2023-04-28","current":-23.815932,"twenty":-29.188024,"median":-21.526909,"eighty":-12.97644,"marketCap":1949429276},{"date":"2023-05-04","current":-25.759189,"twenty":-29.047085,"median":-21.547478,"eighty":-13.010321,"marketCap":2108492618},{"date":"2023-05-12","current":-25.430668,"twenty":-28.87091,"median":-21.684156,"eighty":-13.022106,"marketCap":2275968472},{"date":"2023-05-19","current":-24.709927,"twenty":-28.710998,"median":-21.777538,"eighty":-13.036805,"marketCap":2211464368},{"date":"2023-05-26","current":-24.551205,"twenty":-28.635108,"median":-21.836093,"eighty":-13.095599,"marketCap":2197259175},{"date":"2023-06-02","current":-26.982834,"twenty":-28.385754,"median":-21.975225,"eighty":-13.131082,"marketCap":2414882725},{"date":"2023-06-09","current":-26.976485,"twenty":-28.315219,"median":-21.998414,"eighty":-13.150094,"marketCap":2414314517},{"date":"2023-06-16","current":-28.366895,"twenty":-28.315219,"median":-22.102764,"eighty":-13.18266,"marketCap":2538752003},{"date":"2023-06-23","current":-26.709832,"twenty":-28.306861,"median":-22.335952,"eighty":-13.208307,"marketCap":2390449793},{"date":"2023-06-30","current":-27.198697,"twenty":-28.268754,"median":-22.446731,"eighty":-13.258915,"marketCap":2434201786},{"date":"2023-07-07","current":-25.414655,"twenty":-28.133689,"median":-22.531756,"eighty":-13.410685,"marketCap":2274535423},{"date":"2023-07-14","current":-26.627296,"twenty":-28.013291,"median":-22.709537,"eighty":-13.436068,"marketCap":2383063093},{"date":"2023-07-21","current":-28.538315,"twenty":-28.133689,"median":-22.767353,"eighty":-13.469912,"marketCap":2554093611},{"date":"2023-07-28","current":-29.477953,"twenty":-28.312487,"median":-22.83321,"eighty":-13.57127,"marketCap":2638188351},{"date":"2023-08-04","current":-28.862109,"twenty":-28.557674,"median":-22.893801,"eighty":-13.610321,"marketCap":2583072204},{"date":"2023-08-11","current":-24.764415,"twenty":-28.557674,"median":-23.065098,"eighty":-13.658962,"marketCap":2479438043},{"date":"2023-08-18","current":-23.414561,"twenty":-28.426575,"median":-23.157853,"eighty":-13.68205,"marketCap":2344289281},{"date":"2023-08-25","current":-23.824644,"twenty":-28.373244,"median":-23.263269,"eighty":-13.705606,"marketCap":2385347133},{"date":"2023-09-01","current":-25.954793,"twenty":-28.336421,"median":-23.39747,"eighty":-13.749072,"marketCap":2598619862},{"date":"2023-09-08","current":-26.99139,"twenty":-28.32557,"median":-23.414561,"eighty":-13.761194,"marketCap":2702404987},{"date":"2023-09-15","current":-27.338821,"twenty":-28.315219,"median":-23.555926,"eighty":-13.769146,"marketCap":2737190112},{"date":"2023-09-22","current":-24.587852,"twenty":-28.305414,"median":-23.621628,"eighty":-13.830806,"marketCap":2461760356},{"date":"2023-09-29","current":-26.518657,"twenty":-28.280196,"median":-23.696285,"eighty":-13.88343,"marketCap":2655074408},{"date":"2023-10-06","current":-35.546163,"twenty":-28.305414,"median":-23.77622,"eighty":-13.903115,"marketCap":3558917393},{"date":"2023-10-13","current":-34.236178,"twenty":-28.379593,"median":-23.8154,"eighty":-13.955573,"marketCap":3427760367},{"date":"2023-10-20","current":-29.064584,"twenty":-28.744733,"median":-23.845786,"eighty":-14.026646,"marketCap":2909975237},{"date":"2023-10-27","current":-33.614382,"twenty":-28.862109,"median":-23.861246,"eighty":-14.053721,"marketCap":3365505501},{"date":"2023-11-03","current":-34.337138,"twenty":-29.211299,"median":-23.903358,"eighty":-14.060633,"marketCap":3437868548},{"date":"2023-11-10","current":-35.464886,"twenty":-29.44822,"median":-23.947665,"eighty":-14.060633,"marketCap":3550779854},{"date":"2023-11-17","current":-31.866939,"twenty":-29.833491,"median":-23.964282,"eighty":-14.121409,"marketCap":3634424412},{"date":"2023-11-24","current":-34.755447,"twenty":-30.824236,"median":-23.993876,"eighty":-14.178851,"marketCap":3963858712},{"date":"2023-12-01","current":-35.89767,"twenty":-31.144585,"median":-24.054485,"eighty":-14.230533,"marketCap":4094129310},{"date":"2023-12-08","current":-38.896007,"twenty":-31.669705,"median":-24.123342,"eighty":-14.266938,"marketCap":4436089628},{"date":"2023-12-15","current":-43.38253,"twenty":-31.894239,"median":-24.22903,"eighty":-14.297696,"marketCap":4947777505},{"date":"2023-12-22","current":-38.720281,"twenty":-32.410785,"median":-24.257295,"eighty":-14.315478,"marketCap":4416047998},{"date":"2023-12-29","current":-41.224386,"twenty":-32.610609,"median":-24.317291,"eighty":-14.330209,"marketCap":4701641231},{"date":"2024-01-05","current":-39.862504,"twenty":-32.805979,"median":-24.337125,"eighty":-14.347886,"marketCap":4546318596},{"date":"2024-01-12","current":-40.768595,"twenty":-33.028713,"median":-24.382811,"eighty":-14.347886,"marketCap":4649658252},{"date":"2024-01-19","current":-40.362227,"twenty":-33.4798,"median":-24.425506,"eighty":-14.383306,"marketCap":4603311982},{"date":"2024-01-26","current":-41.899836,"twenty":-34.069015,"median":-24.465511,"eighty":-14.439543,"marketCap":4778676248},{"date":"2024-02-02","current":-42.657657,"twenty":-34.347946,"median":-24.545441,"eighty":-14.462864,"marketCap":4865105779},{"date":"2024-02-09","current":-44.25018,"twenty":-34.775757,"median":-24.580747,"eighty":-14.478998,"marketCap":5046733055},{"date":"2024-02-16","current":-46.402832,"twenty":-34.95921,"median":-24.709927,"eighty":-14.504403,"marketCap":5292243027},{"date":"2024-02-23","current":-45.705417,"twenty":-35.262302,"median":-24.734689,"eighty":-14.556028,"marketCap":5212702806},{"date":"2024-03-01","current":-42.698561,"twenty":-35.546163,"median":-24.77209,"eighty":-14.598111,"marketCap":5389369708},{"date":"2024-03-08","current":-42.363551,"twenty":-36.021716,"median":-24.804256,"eighty":-14.610096,"marketCap":5347085067},{"date":"2024-03-15","current":-42.942205,"twenty":-36.558528,"median":-24.831986,"eighty":-14.622658,"marketCap":5420122174},{"date":"2024-03-22","current":-40.373794,"twenty":-36.868914,"median":-24.992974,"eighty":-14.641549,"marketCap":5095939926},{"date":"2024-03-28","current":-38.90178,"twenty":-37.200741,"median":-25.005225,"eighty":-14.658707,"marketCap":4910143776},{"date":"2024-04-05","current":-36.495798,"twenty":-37.374818,"median":-25.061735,"eighty":-14.675345,"marketCap":4606463172},{"date":"2024-04-12","current":-34.516193,"twenty":-37.267525,"median":-25.09025,"eighty":-14.735959,"marketCap":4356599384},{"date":"2024-04-19","current":-32.008693,"twenty":-37.255768,"median":-25.199563,"eighty":-14.847142,"marketCap":4040105252},{"date":"2024-04-26","current":-33.536542,"twenty":-37.200741,"median":-25.298949,"eighty":-14.916986,"marketCap":4232948842},{"date":"2024-05-03","current":-37.038357,"twenty":-37.101882,"median":-25.381429,"eighty":-14.992892,"marketCap":4674944398},{"date":"2024-05-10","current":-29.955741,"twenty":-36.987234,"median":-25.430668,"eighty":-15.077502,"marketCap":4358829897},{"date":"2024-05-17","current":-32.227266,"twenty":-36.898587,"median":-25.520776,"eighty":-15.184387,"marketCap":4689357283},{"date":"2024-05-24","current":-29.583069,"twenty":-36.872823,"median":-25.569485,"eighty":-15.320748,"marketCap":4304602748},{"date":"2024-05-31","current":-29.494337,"twenty":-36.839925,"median":-25.653696,"eighty":-15.399184,"marketCap":4291691522},{"date":"2024-06-07","current":-36.206872,"twenty":-36.753783,"median":-25.749363,"eighty":-15.460497,"marketCap":5268425769},{"date":"2024-06-14","current":-35.040054,"twenty":-36.747932,"median":-25.822877,"eighty":-15.703127,"marketCap":5098643147},{"date":"2024-06-21","current":-34.782732,"twenty":-36.712369,"median":-25.874326,"eighty":-15.710732,"marketCap":5061200592},{"date":"2024-06-28","current":-34.148302,"twenty":-36.661942,"median":-25.890823,"eighty":-15.727693,"marketCap":4968885326},{"date":"2024-07-05","current":-31.965508,"twenty":-36.495798,"median":-25.923936,"eighty":-15.787932,"marketCap":4651269166},{"date":"2024-07-12","current":-34.600833,"twenty":-36.461894,"median":-25.988967,"eighty":-15.815036,"marketCap":5034732578},{"date":"2024-07-15","current":-34.893647,"twenty":-36.45154,"median":-26.009223,"eighty":-15.833901,"marketCap":5077339624},{"date":"2024-08-02","current":-33.815559,"twenty":-36.441187,"median":-26.02948,"eighty":-15.852766,"marketCap":4920468228},{"date":"2024-08-09","current":-26.219913,"twenty":-36.38746,"median":-26.039924,"eighty":-15.936679,"marketCap":4551383634},{"date":"2024-08-16","current":-26.843308,"twenty":-36.294826,"median":-26.091487,"eighty":-16.068186,"marketCap":4659595631},{"date":"2024-08-23","current":-30.983098,"twenty":-36.163411,"median":-26.131203,"eighty":-16.227286,"marketCap":5378201049},{"date":"2024-08-30","current":-31.916324,"twenty":-36.072704,"median":-26.182617,"eighty":-16.27309,"marketCap":5540195056},{"date":"2024-09-06","current":-31.714747,"twenty":-36.030193,"median":-26.219913,"eighty":-16.289352,"marketCap":5505204350},{"date":"2024-09-13","current":-30.490355,"twenty":-36.010736,"median":-26.305926,"eighty":-16.294773,"marketCap":5292668213},{"date":"2024-09-20","current":-41.470105,"twenty":-36.185141,"median":-26.404281,"eighty":-16.320196,"marketCap":7198588141},{"date":"2024-09-27","current":-41.023082,"twenty":-36.489017,"median":-26.487136,"eighty":-16.335438,"marketCap":7120991681},{"date":"2024-10-04","current":-42.063985,"twenty":-36.839925,"median":-26.521016,"eighty":-16.36506,"marketCap":7301676910},{"date":"2024-10-11","current":-41.629121,"twenty":-37.123057,"median":-26.535236,"eighty":-16.487703,"marketCap":7226190975},{"date":"2024-10-18","current":-41.519389,"twenty":-37.41054,"median":-26.571994,"eighty":-16.548812,"marketCap":7207143122},{"date":"2024-10-25","current":-38.052666,"twenty":-38.109047,"median":-26.647191,"eighty":-16.659123,"marketCap":6605372068},{"date":"2024-10-31","current":-36.674918,"twenty":-38.085179,"median":-26.68862,"eighty":-16.674608,"marketCap":6366215694},{"date":"2024-11-08","current":-38.239617,"twenty":-38.115014,"median":-26.712656,"eighty":-16.695908,"marketCap":6637823966},{"date":"2024-11-15","current":-28.56865,"twenty":-38.204749,"median":-26.80059,"eighty":-16.723012,"marketCap":6407519770},{"date":"2024-11-22","current":-29.37648,"twenty":-38.115014,"median":-26.887601,"eighty":-16.736563,"marketCap":6588703796},{"date":"2024-11-29","current":-30.627824,"twenty":-38.091146,"median":-26.954676,"eighty":-16.844978,"marketCap":6869361404},{"date":"2024-12-06","current":-29.693276,"twenty":-38.059169,"median":-26.97966,"eighty":-16.893765,"marketCap":6659756355},{"date":"2024-12-13","current":-27.504216,"twenty":-37.747042,"median":-27.063091,"eighty":-16.953393,"marketCap":6168783172},{"date":"2024-12-20","current":-26.813601,"twenty":-37.583519,"median":-27.063095,"eighty":-17.053677,"marketCap":6013888593},{"date":"2024-12-27","current":-25.996268,"twenty":-37.492453,"median":-26.987112,"eighty":-17.091622,"marketCap":5830572991},{"date":"2025-01-03","current":-25.340501,"twenty":-37.40921,"median":-26.975395,"eighty":-17.134988,"marketCap":5683494194},{"date":"2025-01-10","current":-24.789276,"twenty":-37.336436,"median":-26.943787,"eighty":-17.189196,"marketCap":5559862741},{"date":"2025-01-17","current":-24.073317,"twenty":-37.267588,"median":-26.849001,"eighty":-17.21901,"marketCap":5399283958},{"date":"2025-01-24","current":-26.515813,"twenty":-37.267337,"median":-26.813601,"eighty":-17.251535,"marketCap":5947099188},{"date":"2025-01-31","current":-27.798837,"twenty":-37.238414,"median":-26.828454,"eighty":-17.305742,"marketCap":6234862052},{"date":"2025-02-07","current":-27.466201,"twenty":-37.144232,"median":-26.880129,"eighty":-17.454813,"marketCap":6160256865},{"date":"2025-02-14","current":-25.644625,"twenty":-37.038357,"median":-26.846155,"eighty":-17.471277,"marketCap":5751704651},{"date":"2025-02-21","current":-26.100811,"twenty":-36.968696,"median":-26.785736,"eighty":-17.56652,"marketCap":5854020336},{"date":"2025-02-28","current":-20.411984,"twenty":-36.918696,"median":-26.712656,"eighty":-17.605929,"marketCap":5322547194},{"date":"2025-03-07","current":-20.027736,"twenty":-36.886624,"median":-26.694963,"eighty":-17.787173,"marketCap":5222352284},{"date":"2025-03-14","current":-20.450586,"twenty":-36.865624,"median":-26.667087,"eighty":-17.99777,"marketCap":5332613081},{"date":"2025-03-21","current":-21.318253,"twenty":-36.86125,"median":-26.590122,"eighty":-18.067045,"marketCap":5558862508},{"date":"2025-03-28","current":-20.214449,"twenty":-36.776416,"median":-26.54476,"eighty":-18.073973,"marketCap":5271038870},{"date":"2025-04-04","current":-18.759184,"twenty":-36.749395,"median":-26.523364,"eighty":-18.088195,"marketCap":4891569894},{"date":"2025-04-11","current":-17.021104,"twenty":-36.712369,"median":-26.515813,"eighty":-17.99777,"marketCap":4438355060},{"date":"2025-04-17","current":-19.212238,"twenty":-36.686342,"median":-26.48036,"eighty":-18.046198,"marketCap":5009706462},{"date":"2025-04-25","current":-20.313297,"twenty":-36.567446,"median":-26.420448,"eighty":-18.064693,"marketCap":5296814121},{"date":"2025-05-02","current":-20.931098,"twenty":-36.475456,"median":-26.315342,"eighty":-18.073973,"marketCap":5457909441},{"date":"2025-05-09","current":-17.089596,"twenty":-36.430833,"median":-26.28219,"eighty":-18.073973,"marketCap":5141507574},{"date":"2025-05-16","current":-16.946387,"twenty":-36.395868,"median":-26.219913,"eighty":-17.80499,"marketCap":5098422315},{"date":"2025-05-23","current":-17.478647,"twenty":-36.366622,"median":-26.183178,"eighty":-17.602029,"marketCap":5258555860},{"date":"2025-05-30","current":-17.84383,"twenty":-36.316227,"median":-26.173393,"eighty":-17.576984,"marketCap":5368423271},{"date":"2025-06-06","current":-18.638639,"twenty":-36.238974,"median":-26.132081,"eighty":-17.5849,"marketCap":5607546458},{"date":"2025-06-13","current":-18.595677,"twenty":-36.163411,"median":-26.113701,"eighty":-17.59813,"marketCap":5594620881},{"date":"2025-06-20","current":-18.027615,"twenty":-36.085461,"median":-26.070805,"eighty":-17.639806,"marketCap":5423716020},{"date":"2025-06-27","current":-18.886868,"twenty":-36.030193,"median":-26.0467,"eighty":-17.760818,"marketCap":5682227574},{"date":"2025-07-03","current":-19.209088,"twenty":-36.013239,"median":-26.033148,"eighty":-17.765211,"marketCap":5779169407},{"date":"2025-07-11","current":-19.588592,"twenty":-36.000722,"median":-25.992618,"eighty":-17.808028,"marketCap":5893345343},{"date":"2025-07-14","current":-19.316495,"twenty":-35.989565,"median":-25.988967,"eighty":-17.812724,"marketCap":5811483351}],"updateTime":1752595989942}}}